143 related articles for article (PubMed ID: 6821383)
1. Saturnine gout: a review of 42 patients.
Halla JT; Ball GV
Semin Arthritis Rheum; 1982 Feb; 11(3):307-14. PubMed ID: 6821383
[No Abstract] [Full Text] [Related]
2. The role of lead in gout nephropathy.
Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP
N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160
[No Abstract] [Full Text] [Related]
3. The role of lead in gout nephropathy reviewed: pathogenic or associated factor?
Miranda ME; Puig JG; Mateos FA; Ramos TH; Herrero E; González A; Gil A; Vázquez JO
Adv Exp Med Biol; 1991; 309A():209-12. PubMed ID: 1789210
[No Abstract] [Full Text] [Related]
4. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
Orfanos CE; Künzig M
Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
[TBL] [Abstract][Full Text] [Related]
5. Lennox's syndrome and lead intoxication.
Fejerman N; Gimenez ER; Vallejo NE; Medina CS
Pediatrics; 1973 Aug; 52(2):227-34. PubMed ID: 4198493
[No Abstract] [Full Text] [Related]
6. Red blood cell beta-aminolevulinic acid dehydrase activity. An index of body lead burden.
Nieburg PI; Weiner LS; Oski B; Oski FA
Am J Dis Child; 1974 Mar; 127(3):348-50. PubMed ID: 4205496
[No Abstract] [Full Text] [Related]
7. Moonshine and lead. Relationship to the pathogenesis of hyperuricemia in gout.
Reynolds PP; Knapp MJ; Baraf HS; Holmes EW
Arthritis Rheum; 1983 Sep; 26(9):1057-64. PubMed ID: 6412722
[No Abstract] [Full Text] [Related]
8. The clinical differentiation of lead gout from primary gout.
Emmerson BT
Arthritis Rheum; 1968 Oct; 11(5):623-34. PubMed ID: 5680985
[No Abstract] [Full Text] [Related]
9. Saturnine gout.
Ehrlich GE; Chokatos J
Arch Intern Med; 1966 Dec; 118(6):572-4. PubMed ID: 5925445
[No Abstract] [Full Text] [Related]
10. [Extensive, generalized form of saturnine paralysis].
Buge A; Moreau L; Bestel B; Philbert L; Poisson M; Rancurel G; Valcke JL
Ann Med Interne (Paris); 1974 Feb; 125(2):207-12. PubMed ID: 4212654
[No Abstract] [Full Text] [Related]
11. [Usefulness of 10 biochemical parameters and dose/response curves in the diagnosis of 68 cases of acute poisoning with inorganic lead].
Cartón Sánchez JA; Arribas Castrillo JM; Cabeza González de la Fuente JM; Vallina Alvarez E; Díaz Sánchez J
Med Clin (Barc); 1985 Mar; 84(12):465-9. PubMed ID: 3927078
[No Abstract] [Full Text] [Related]
12. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
[TBL] [Abstract][Full Text] [Related]
13. Saturnine gout, redux: a review.
Dalvi SR; Pillinger MH
Am J Med; 2013 May; 126(5):450.e1-8. PubMed ID: 23510947
[TBL] [Abstract][Full Text] [Related]
14. Chronic lead nephropathy.
Emmerson BT
Kidney Int; 1973 Jul; 4(1):1-5. PubMed ID: 4353288
[No Abstract] [Full Text] [Related]
15. Saturnine gout--a moonshine malady.
Klinenberg JR
N Engl J Med; 1969 May; 280(22):1238-9. PubMed ID: 5767467
[No Abstract] [Full Text] [Related]
16. Laboratory diagnosis of increased lead absorption.
Baloh RW
Arch Environ Health; 1974 Apr; 28(4):198-208. PubMed ID: 4205503
[No Abstract] [Full Text] [Related]
17. Serial measurements of aminolevulinic acid dehydratase in children with lead toxicity.
Morris V; Markowitz ME; Rosen JF
J Pediatr; 1988 Jun; 112(6):916-9. PubMed ID: 3131512
[No Abstract] [Full Text] [Related]
18. Occult lead intoxication in patients with gout and kidney disease.
Wright LF; Saylor RP; Cecere FA
J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
[TBL] [Abstract][Full Text] [Related]
19. Lead poisoning in inherited delta-aminolevulinic acid dehydratase deficiency.
Doss M; Laubenthal F; Stoeppler M
Int Arch Occup Environ Health; 1984; 54(1):55-63. PubMed ID: 6427116
[TBL] [Abstract][Full Text] [Related]
20. Requiem for gouty nephropathy.
Beck LH
Kidney Int; 1986 Aug; 30(2):280-7. PubMed ID: 3761864
[No Abstract] [Full Text] [Related]
[Next] [New Search]
